Fluoro-L-thymidine

DRUG2 trials

Sponsors

University of Cologne, Columbia University

Conditions

Esophageal CancerNon-Small-Cell Lung CarcinomaNon-small Cell Lung Cancer

Phase 2

Molecular Imaging With Erlotinib and Bevacizumab

CompletedNCT01047059

University of CologneNon-Small-Cell Lung Carcinoma

Start: 2010-01-31End: 2016-05-31Updated: 2016-05-20

Unknown Phase

Early Prediction of Pathology Response of Chemoradiotherapy With FLT PET

TerminatedNCT01065818

Columbia UniversityEsophageal Cancer, Non-small Cell Lung Cancer

Start: 2009-08-31End: 2013-02-28Updated: 2017-09-26

Related Papers

MIMEB: A phase II trial to evaluate FDG-PET/FLT-PET, DCE-MRI and molecular biomarkers for early prediction of nonprogression in patients with advanced non-small cell lung cancer treated with erlotinib and bevacizumab.

Journal of Clinical Oncology2014-05-20